학술논문
Updated Results from MajesTEC-1: Phase 1/2 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma
Document Type
ConferencePaper
Author
Moreau, P; Usmani, SZ; Garfall, AL; de Donk, NWV; Nahi, H; San-Miguel, J; Oriol, A; Nooka, AK; Martin, T; Rosino, L; Chari, A; Karlin, L; Benboubker, L; Mateos, MV; Bahlis, NJ; Popat, R; Besemer, B; Martinez-Lopez, J; Sidana, S; Pei, L; Trancucci, D; Verona, RI; Girgis, S; Olyslager, Y; Jaffe, M; Uhlar, CM; Stephenson, T; Van Rampelbergh, R; Banerjee, A; Goldberg, JD; Kobos, R; Krishnan, AY
Source
BLOOD. 138
Subject
Language
English
English
English
ISSN
0006-4971